BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,079 filers reported holding BAXTER INTL INC in Q3 2019. The put-call ratio across all filers is 0.52 and the average weighting 0.3%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $2,057,000 | +3.4% | 23,363 | -3.8% | 0.50% | +3.7% |
| Q2 2019 | $1,989,000 | -23.7% | 24,283 | -24.7% | 0.49% | -29.3% |
| Q1 2019 | $2,607,000 | +34.2% | 32,233 | +9.2% | 0.69% | +9.2% |
| Q4 2018 | $1,943,000 | -9.0% | 29,513 | -2.1% | 0.63% | -1.1% |
| Q3 2018 | $2,136,000 | +10.4% | 30,140 | +1.3% | 0.64% | -1.4% |
| Q2 2018 | $1,934,000 | 0.0% | 29,743 | 0.0% | 0.65% | +1.7% |
| Q1 2018 | $1,934,000 | +11.1% | 29,743 | +10.5% | 0.64% | +6.4% |
| Q4 2017 | $1,740,000 | +32.2% | 26,913 | +28.4% | 0.60% | +24.8% |
| Q3 2017 | $1,316,000 | +53.6% | 20,967 | +48.2% | 0.48% | +41.3% |
| Q2 2017 | $857,000 | +26.6% | 14,150 | +8.4% | 0.34% | +14.5% |
| Q1 2017 | $677,000 | +13.8% | 13,055 | -2.8% | 0.30% | +13.0% |
| Q4 2016 | $595,000 | -10.8% | 13,425 | -4.2% | 0.26% | -9.3% |
| Q3 2016 | $667,000 | -44.5% | 14,015 | -47.3% | 0.29% | -42.4% |
| Q2 2016 | $1,202,000 | -22.5% | 26,585 | -29.6% | 0.50% | -26.0% |
| Q1 2016 | $1,550,000 | -20.5% | 37,736 | -26.2% | 0.68% | -24.0% |
| Q4 2015 | $1,950,000 | -12.2% | 51,109 | -24.4% | 0.89% | -37.8% |
| Q3 2015 | $2,220,000 | -47.4% | 67,595 | +12.1% | 1.44% | -45.0% |
| Q2 2015 | $4,217,000 | +1.6% | 60,315 | -1.0% | 2.61% | -7.1% |
| Q1 2015 | $4,149,000 | -8.3% | 60,930 | -1.4% | 2.81% | -10.6% |
| Q4 2014 | $4,527,000 | – | 61,765 | – | 3.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 298,721 | $23,969,000 | 8.70% |
| GENERATION INVESTMENT MANAGEMENT LLP | 17,424,560 | $1,398,147,000 | 6.24% |
| Soditic Asset Management LLP | 77,950 | $6,255,000 | 6.24% |
| Veritas Asset Management LLP | 11,110,132 | $891,477,000 | 5.32% |
| Dash Acquisitions Inc. | 84,560 | $6,785,000 | 4.74% |
| Prosight Management, LP | 121,075 | $9,715,000 | 4.49% |
| TSFG, LLC | 94,977 | $7,621,000 | 4.07% |
| CINCINNATI FINANCIAL CORP | 1,344,648 | $107,895,000 | 2.93% |
| Dundas Partners LLP | 204,535 | $19,304,000 | 2.82% |
| Unified Trust Company, N.A. | 59,491 | $4,689,000 | 2.72% |